Formulation, Characterization And Evaluation Of Curcumin- Loaded PLGA- TPGS Nanoparticles For Liver Cancer Treatment

References

• Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27(9):1485–1491. doi:10.1200/JCO.2008.20.775319224838
   PubMed Web of Science ®Google Scholar
• Villanueva A, Llovet JM. Targeted therapies for hepatocellular carcinoma. Gastroenterology. 2011;140(5):1410–1426. doi:10.1053/j.gastro.2011.03.00621406195
   PubMed Web of Science ®Google Scholar
• Asghar U, Meyer T. Are there opportunities for chemotherapy in the treatment of hepatocellular cancer? J Hepatol. 2012;56(3):686–695. doi:10.1016/j.jhep.2011.07.03121971559
   PubMed Web of Science ®Google Scholar
• Ren J, Xu Y, Huang Q, et al. Chabamide induces cell cycle arrest and apoptosis by the Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells. Anticancer Drugs. 2015;26(5):498–507. doi:10.1097/CAD.000000000000020925714087
   PubMed Web of Science ®Google Scholar
• Tham CL, Hazeera HH, Wai LK, et al. The synthetic curcuminoid BHMC restores endotoxin-stimulated HUVEC dysfunction: specific disruption on enzymatic activity of p38 MAPK. Eur J Pharmacol. 2015;749:1–11. doi:10.1016/j.ejphar.2014.12.01525560198
   PubMed Web of Science ®Google Scholar
• Akkoc Y, Berrak Ö, Arisan ED, et al. Inhibition of P13k signaling triggered apoptotic potential of curcumin which is hindered by Bcl-2 through activation of autophagy in MCF-7 cells. Biomed Pharmacother. 2015;71:161–171. doi:10.1016/j.biopha.2015.02.02925960232
   PubMed Web of Science ®Google Scholar
• Troselj KG, Kujundzic RN. Curcumin in combined cancer therapy. Curr Pharm Des. 2014;20(42):6682–6696. doi:10.2174/138161282066614082615460125341940
   PubMed Web of Science ®Google Scholar
• Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C. Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res. 2015;35(2):645–651.25667441
   PubMed Web of Science ®Google Scholar
• Hu A, Huang JJ, Jin XJ, et al. Curcumin suppresses invasiveness and vasculogenic mimicry of squamous cell carcinoma of the larynx through the inhibition of JAK-2/STAT-3 signaling pathway. Am J Cancer Res. 2014;5(1):278–288.25628937
   PubMed Web of Science ®Google Scholar
• Zhang C, Li B, Zhang X, et al. Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients’ PBMCs: potential role for STAT-3 and NF-κB signaling. J Invest Dermatol. 2010;130(8):2110–2119. doi:10.1038/jid.2010.8620393484
   PubMed Web of Science ®Google Scholar
• Chiablaem K, Lirdprapamongkol K, Keeratichamroen S, Surarit R, Svasti J. Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition. Anticancer Res. 2014;34(4):1857–1864.24692720
   PubMed Web of Science ®Google Scholar
• Jung KT, Lim KJ. Curcumin, COX-2 and protein p300/CBP. Korean J Pain. 2014;27(4):365–366. doi:10.3344/kjp.2014.27.4.36525317287
   PubMedGoogle Scholar
• Shishodia S. Molecular mechanisms of curcumin action: gene expression. Biofactors. 2013;39(1):37–55. doi:10.1002/biof.104122996381
   PubMed Web of Science ®Google Scholar
• Zheng J, Zhou Y, Li Y, Xu D-P, Li S, Li H-B. Spices for prevention and treatment of cancers. Nutrients. 2016;8(8):495. doi:10.3390/nu8080495
   PubMed Web of Science ®Google Scholar
• Heath DD, Pruitt MA, Brenner DE, Rock CL. Curcumin in plasma and urine: quantitation by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;783(1):287–295. doi:10.1016/s1570-0232(02)00714-6
   PubMed Web of Science ®Google Scholar
• Singh SP, Sharma M, Gupta PK. Cytotoxicity of curcumin silica nanoparticle complexes conjugated with hyaluronic acid on colon cancer cells. Int J Biol Macromol. 2015;74:162–170. doi:10.1016/j.ijbiomac.2014.11.03725511568
   PubMed Web of Science ®Google Scholar
• Shinde RL, Devarajan PV. Docosahexaenoic acid-mediated, targeted and sustained brain delivery of curcumin microemulsion. Drug Deliv. 2017;24(1):152. doi:10.1080/10717544.2016.126782228156175
   PubMed Web of Science ®Google Scholar
• Wei X, Senanayake TH, Bohling A, Vinogradov SV. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition. Mol Pharm. 2014;11(9):3112–3122. doi:10.1021/mp500290f25072100
   PubMed Web of Science ®Google Scholar
• Jyoti K, Bhatia RK, Martis EAF, et al. Soluble curcumin amalgamated chitosan microspheres augmented drug delivery and cytotoxicity in colon cancer cells: in vitro, and in vivo, study. Colloids Surf B Biointerfaces. 2016;148:674–683. doi:10.1016/j.colsurfb.2016.09.04427701049
   PubMed Web of Science ®Google Scholar
• Kim S, Diab R, Joubert O, Canilho N, Pasc A. Core-shell microcapsules of solid lipid nanoparticles and mesoporous silica for enhanced oral delivery of curcumin. Colloids Surf B Biointerfaces. 2016;140:161–168. doi:10.1016/j.colsurfb.2015.12.04026752213
   PubMed Web of Science ®Google Scholar
• Kotcherlakota R, Barui AK, Prashar S, et al. Curcumin loaded mesoporous silica: an effective drug delivery system for cancer treatment. Biomater Sci. 2016;4(3):448. doi:10.1039/C5BM00552C26674254
   PubMed Web of Science ®Google Scholar
• Bollu VS, Barui AK, Mondal SK, et al. Curcumin-loaded silica-based mesoporous materials: synthesis, characterization and cytotoxic properties against cancer cells. Mater Sci Eng C Mater Biol Appl. 2016;63:393–410. doi:10.1016/j.msec.2016.03.01127040234
   PubMed Web of Science ®Google Scholar
• Spencer DS, Puranik AS, Peppas NA. Intelligent nanoparticles for advanced drug delivery in cancer treatment. Curr Opin Chem Eng. 2015;7:84–92. doi:10.1016/j.coche.2014.12.00325621200
   PubMed Web of Science ®Google Scholar
• Truong NP, Whittaker MR, Mak CW, Davis TP. The importance of nanoparticle shape in cancer drug delivery. Expert Opin Drug Deliv. 2015;12:129–142. doi:10.1517/17425247.2014.95056425138827
   PubMed Web of Science ®Google Scholar
• Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials. 2000;21:2475–2490. doi:10.1016/s0142-9612(00)00115-011055295
   PubMed Web of Science ®Google Scholar
• Collnot EM, Baldes C, Wempe MF, et al. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity. Mol Pharm. 2007;4:465–474. doi:10.1021/mp060121r17367162
   PubMed Web of Science ®Google Scholar
• Guo Y, Luo J, Tan S, Otieno BO, Zhang Z. The applications of Vitamin E TPGS in drug delivery. Eur J Pharm Sci. 2013;49(2):175–186. doi:10.1016/j.ejps.2013.02.00623485439
   PubMed Web of Science ®Google Scholar
• Song IS, Cha JS, Choi MK. Characterization, in vivo and in vitro evaluation of solid dispersion of curcumin containing d-α-Tocopheryl polyethylene glycol 1000 succinate and mannitol. Molecules. 2016;21(10):1386. doi:10.3390/molecules21101386
   PubMed Web of Science ®Google Scholar
• Chen HB, Zheng Y, Tian G, et al. Oral delivery of DMABmodified docetaxel-loaded PLGA-TPGS nanoparticles for cancer chemotherapy. Nanoscale Res Lett. 2011;6(1):4.27502629
   PubMed Web of Science ®Google Scholar
• Ma Y, Zheng Y, Liu K, et al. Nanoparticles of poly(lactide-coglycolide)-d-a-tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatment. Nanoscale Res Lett. 2010;5:1161–1169. doi:10.1007/s11671-010-9620-320596457
   PubMed Web of Science ®Google Scholar
• Braden ARC, Vishwanatha JK Formulation of active agentloaded activated PLGA nanoparticles for targeted cancer nanotherapeutics. US Patent Application Publication 0253961 A1. 2008.
   Google Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5(1):37–42. doi:10.1016/0168-3659(87)90035-6
   Google Scholar
• Song J, Huang H, Xia Z, et al. TPGS/Phospholipids mixed micelles for delivery of Icariside II to multidrug-resistant breast cancer. Integr Cancer Ther. 2016;15(3):390–399. doi:10.1177/153473541559657126293804
   PubMed Web of Science ®Google Scholar
• Assanhou AG, Li W, Zhang L, et al. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Biomaterials. 2015;73:284–295. doi:10.1016/j.biomaterials.2015.09.02226426537
   PubMed Web of Science ®Google Scholar